Thompson Davis & Co’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,150
| Closed | -$241K | – | 149 |
|
|
2021
Q4 | $241K | Buy |
+2,150
| New | +$241K | 0.2% | 87 |
|
|
2018
Q3 | $380K | Buy |
3,960
+625
| +19% | +$60K | 0.83% | 26 |
|
|
2018
Q2 | $317K | Hold |
3,335
| – | – | 0.75% | 34 |
|
|
2018
Q1 | $293K | Buy |
3,335
+85
| +3% | +$7.47K | 0.77% | 32 |
|
|
2017
Q4 | $276K | Sell |
3,250
-2,002
| -38% | -$170K | 0.65% | 31 |
|
|
2017
Q3 | $455K | Buy |
5,252
+1,126
| +27% | +$97.6K | 0.81% | 20 |
|
|
2017
Q2 | $318K | Buy |
4,126
+1,876
| +83% | +$145K | 0.51% | 49 |
|
|
2017
Q1 | $156K | Buy |
2,250
+2,000
| +800% | +$139K | 0.22% | 96 |
|
|
2016
Q4 | $15K | Hold |
250
| – | – | 0.02% | 598 |
|
|
2016
Q3 | $17K | Hold |
250
| – | – | 0.03% | 533 |
|
|
2016
Q2 | $14K | Buy |
250
+125
| +100% | +$7K | 0.02% | 569 |
|
|
2016
Q1 | $6K | Sell |
125
-500
| -80% | -$24K | 0.01% | 759 |
|
|
2015
Q4 | $44K | Buy |
+625
| New | +$44K | 0.06% | 283 |
|